Filter
1120
Text search:
drug-resistant
TB
Featured
120
307
Language
Document type
738
126
110
36
35
34
22
14
2
1
1
1
Countries / Regions
54
52
41
37
35
20
20
20
19
19
19
19
18
16
15
15
14
13
13
12
12
12
11
11
11
10
9
7
6
6
6
6
5
5
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
441
101
30
15
14
10
9
Toolboxes
545
84
71
17
17
16
15
13
12
11
10
10
9
4
3
3
3
2
2
2
2
1
1
Evaluation report
December 2014
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
Guidance for health workers
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Primary Care: The Community Health System
Draft version
Celebrating ten years of success 2004-2014
NHSP 2017- 2022 (Final draft)
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
